Government and Taxes: Covid 26, CDC PH Statement on Ivermectin

Saturday, March 20, 2021

Covid 26, CDC PH Statement on Ivermectin

Concerned Doctors and Citizens of the Philippines (CDCPh)

Statement on Ivermectin
March 18, 2021

We at the Concerned Doctors and Citizens of the Philippines would like to share the good news with all Filipinos. Today 22% of the world is already using Ivermectin to successfully fight COVID-19. Multiple studies and meta-analyses confirm the effectiveness of Ivermectin, a safe oral drug used for over 40 years for other illnesses in humans. Below is a summary of some of the scientific evidences including citations to the four meta analysis supporting the use of Ivermectin vs. COVID-19.

1) 100% of the 46 studies to date report positive effects (22 statistically significant in isolation). Random effects meta-analysis for early treatment and pooled effects shows a 79% reduction, Prophylactic use shows 89% improvement, Mortality results show 75% lower mortality, for all treatment delays, and 84% lower, for early treatment.

2) 100% of the 24 Randomized Controlled Trials (RCTs) report positive effects with an estimated 70% improvement, RR 0.30

3) There at least four meta-analyses in pre print headed by the authors Lawrie ( Bryant), Hill, Nardelli and Kory confirming the efficacy of Ivermectin against COVID-19 are in preprint and available on-line.

Bryant et al., OSF Preprints, Ivermectin for prevention and treatment of COVID-19 infection: a systematic review and meta-analysis, https://osf.io/k37ft/.
Nardelli et al., Signa Vitae, doi:10.22514/sv.2021.043 (Peer Reviewed)

Crying wolf in time of Corona: the strange case of ivermectin and hydroxychloroquine. Is the fear of failure withholding potential life-saving treatment from clinical use? https://oss.signavitae.com/mre-signavitae/article/20210312-306/pdf/SV2021022602.pdf

Hill et al., Research Square, doi:10.21203/rs.3.rs-148845/v1, Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection, https://www.researchsquare.com/article/rs-148845/v1

Kory et al., FLCCC Alliance, Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19, https://covid19criticalcare.com/wp-content/uploads/2020/11/FLCCC-Ivermectin-in-the-prophylaxis-and-treatment-of-COVID-19.pdf.

Source: https://ivmmeta.com

The BIRD meta-analysis by Dr. Tess Lawrie has already been sent for urgent action to the World Health Organization.

Ivermectin is a cheap, safe and efficacious drug against COVID-19. It is our obligation as ethical and responsible doctors and citizens to urgently and highly recommend its use considering the on-going pandemic. The Philippines with its scarce supply of vaccines cannot just sit around waiting while our countrymen continue to suffer the various consequences of this crisis.
--------------

The statement was principally written by Dr. Benigno "Iggy" Agbayani, President of CDC Ph. You may find forwards/shares of that statement but with altered and distorted sentences, ignore them. Additional discussions from the above links:

(1) Dr Andrew Hill + 29 authors from UK, France, India, Egypt,...,
"Preliminary meta-analysis of randomized trials of ivermectin to treat SARSCoV-2 infection" (37 pages) https://assets.researchsquare.com/files/rs-148845/v1_stamped.pdf

"Results: ... In six RCTs of moderate or severe infection, there was a 75% reduction in mortality (Relative Risk=0.25 [95%CI 0.12-0.52]; p=0.0002); 14/650 (2.1%) deaths on ivermectin; 57/597 (9.5%) deaths in controls) with favorable clinical recovery and reduced hospitalization."

(2) Dr. Pierre Kory + 9 authors from US, UK, Norway,...,
"Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19" (30 pages),
https://covid19criticalcare.com/wp-content/uploads/2020/11/FLCCC-Ivermectin-in-the-prophylaxis-and-treatment-of-COVID-19.pdf

"In summary, based on the existing and cumulative body of evidence, we recommend the use of ivermectin in both prophylaxis and treatment for COVID-19. In the presence of a global COVID-19 surge, the widespread use of this safe, inexpensive, and effective intervention would lead to a drastic reduction in transmission rates and the morbidity and mortality in mild, moderate, and even severe disease phases."